New associations of human papillomavirus, simian virus 40, and Epstein-Barr virus with human cancer

Journal of the National Cancer Institute

Volumn 94, Issue 24, 2002, Pages 1832-1836

  Wong, May ^a   Pagano, Joseph S ^b   Schiller, John T ^a   Tevethia, Satvir S ^c   Raab Traub, Nancy ^b   Gruber, Jack ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; B CELL LYMPHOMA; BRAIN TUMOR; BREAST CANCER; BURKITT LYMPHOMA; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; DNA SEQUENCE; DRINKING BEHAVIOR; EPSTEIN BARR VIRUS; GENETIC SCREENING; HEAD AND NECK CARCINOMA; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIFESTYLE; MESOTHELIOMA; MOUTH CANCER; NASOPHARYNX CARCINOMA; OSTEOSARCOMA; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; RISK FACTOR; SIMIAN VIRUS 40; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS; WESTERN BLOTTING;

EID: 0037132698     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.24.1832     Document Type: Article

References (56)

1. zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999;111:581-7.
2. Rickinson AB, Kieff E. Epstein-Bar virus. In: Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins Press; 2001. p. 2575-627.
3. Raab-Traub N. Pathogenesis of Epstein-Barr virus and its associated malignancies. Semin Virol 1996;7:305-13.
4. Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 2001;13:183-8.
5. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-31.
6. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001;93:232-5.
7. Snijders PJ, Scholes AG, Hart CA, Jones AS, Vaughan ED, Woolgar JA, et al. Prevelance of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996;66:464-9.
8. Franceschi S, Munoz N, Snijders PJ. How strong and how wide is the link between HPV and oropharyngeal cancer? Lancet 2000;356:871-2.
9. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999;91:1376-81.
10. Takada K. Epstein-Barr virus and gastric carcinoma. J Clin Path 2000;53: 255-61.
11. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumor of childhood. N Engl J Med 1992;326:988-93.
12. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 1999;91: 119-34.
13. Rizzo P, Rocchetta M, Powers A, Foddis R, Stekala E, Pass HI, et al. SV40 and the pathogenesis of mesothelioma. Semin Cancer Biol 2001;11:63-71.
14. Jasani B, Cristando A, Emri SA, Gazdar AF, Gibbs A, Krynska B, et al. Association of SV40 with human tumors. Semin Cancer Biol 2001;11:49-61.
15. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
16. Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 2002;8:1203-9.
17. Xi LF, Koutsky LA, Galloway DA, Hughes JP, Wheeler CM, Holmes KK, et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997:89: 796-802.
18. Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, Kuypers J, et al. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 1998;58:3839-44.
19. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-72.
20. Song S, Pitot HC, Lambert PF. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol 1999; 73:5887-93.
21. Song S, Liem A, Miller JA, Lambert PF. Human papillomavirus types 16 EG and E7 contribute differently to carcinogenesis. Virology 2000;267: 141-50.
22. Kiviat NB. Papillomaviruses in non-melanoma skin cancer: epidemiological aspects. Semin Cancer Biol 1999;9:397-403.
23. de Villers EM, Ruhland A, Sekaric P. Human papillomaviruses in non-melanoma skin cancer. Semin Cancer Biol 1999;9:413-22.
24. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002;15:101-14.
25. Geissler E, Konzer P, Scherneck S, Zimmerman W. Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40. Acta Virol 1985;29:420-3.
26. Shah KV, Ozer HL, Pond HS, Palma LD, Murphy GP. SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature 1971;231:448-9.
27. Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973;2:229-35.
28. Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, et al. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res 1998;58: 4505-9.
29. Stewart AR, Lednicky JA, Butel JS. Sequence analysis of human tumor associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J Neurovirol 1998;4:182-93.
30. Shivapurkar N, Wiethege T, Wistuba II, Salomon E, Milchgrub S, Muller KM, et al. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 1999;76:181-8.
31. Testa JR, Giordano A. SV40 and cell cycle perturbations in malignant mesothelioma. Semin Cancer Biol 2001;11:31-8.
32. Schrump DS, Waheed I. Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesotheliomas. Semin Cancer Biol 2001; 11:73-80.
33. Bocchetta M, DiResta I, Powers A, Fresco R, Tosolini A, Testa JR, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A 2000;97:10214-9.
34. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 199;139:469-74.
35. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-9.
36. Raab-Traub N, Rajadurai P, Flynn K, Lanier AP. Epstein-Barr virus infection in carcinoma of the salivary gland. J Virol 1991;65:7032-6.
37. Weiss LM, Warnke RA, Sklar J. Clonal antigen receptor gene rearrangements and Epstein-Barr viral DNA in tissues of Hodgkin's disease. Hematol Oncol 1988;6:233-8.
38. Imai S, Koizumi S, Sugiura M, Tokynaga M, Uemura Y, Yamamoto N, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A 1994; 91:9131-5.
39. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995;146:1355-67.
40. Gilligan K, Rajadurai P, Resnick L, Raab-Traub N. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci U S A 1990;87:8790-4.
41. Fina F, Romain S, Quafik LK, Palmari J, Ayed FB, Benharkat S, et al. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 2001;84:783-90.
42. Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL. Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancer. Int J Cancer 1998;75:555-8.
43. Brink AA. van den Brule AJ, van Diest P, Meijer CJ. Re: detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 2000;92: 655-6.
44. McCall SA, Lichy JH, Bijawaard KE, Aguilera NS, Chu WS, Taubenberger JK. Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst 2001;93:148-50.
45. Chu JS, Chen CC, Chang KJ. In situ detection of Epstein-Barr virus in breast cancer. Cancer Lett 1998;124:53-7.
46. Chu PG, Chang KL, Chen YY, Chen WG, Weiss LM. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 2001;159:571-8.
47. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Detection of Epstein-Barr virus DNA and RNA in human pharyngeal epithelial cells. N Engl J Med 1984;310:1225-30.
48. Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 1987;61:1416-20.
49. Tanner J, Weiss J, Fearon D, Whang Y, Kieff E. Epstein-Barr virus gp 350/220 binding to the B lymphocyte C3d receptor mediates absorption, capping and endocytosis. Cell 1987;50:203-13.
50. Imai S, Nishikawa J, Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 1998; 72:4371-8.
51. Chang Y, Tung CH, Huang YT, Lu J, Chen JY, Tsai CH. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 1999;73:8857-66.
52. Speck P, Longnecker R. Infection of breast epithelial cells with Epstein-Barr virus via cell-to-cell contact. J. Natl Cancer Inst 2000;92:1849-51.
53. Yoshizaki T, Sato H, Furukawa M, Pagano J. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci U S A 1998;95:3621-6.
54. Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M, et al. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A 2001;98:6905-10.
55. Fredricks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996;9:18-33.
56. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KH. The causal relation between human papillomavirus and cervical cancer. J Clin Path 2002;55: 1-21.